Schwabe Austria

What Schwabe Austria does

Schwabe Austria GmbH is the Austrian subsidiary of the global Schwabe Group (Schwabe-Gruppe), a European pharmaceutical group specializing in phytotherapy. Headquartered in Vienna's 23rd district (Liesing), the company markets and distributes a portfolio of clinically supported plant-based medicinal products, probiotic supplements, and homeopathic medicines across Austria. Its branded phytopharmaceutical portfolio includes Crataegutt® (heart), Kaloba® (colds), Lasea® (anxiety), Passedan® (sleep/calm), Prostagutt® duo (prostate), Reloxan® (reflux), Vitango® (stress/fatigue), Gaspan® (digestion), and the Heel-distributed Traumeel®, Vertigoheel®, and Viburcol® lines; the pegaso® Baby and pegaso® Junior probiotic SKUs extend the portfolio into pediatric microbiome care.

The company operates an exclusively pharmacy-channel distribution model, selling through Austrian Apotheken (in-store and via pharmacy online ordering platforms such as doc.green) and distributing printed patient guidebooks (Ratgeber) and informational brochures to physician offices. Its go-to-market combines three motions: community-led consumer engagement via the Phytofluencer Instagram program, the Fritz Gamerith Phytoblog, the Arzneipflanzengarten medicinal plant garden and 'Tage der Arzneipflanzen' annual event, and the 'Pflanzlich' newsletter; channel-partner distribution through pharmacies and physicians; and B2B sales-led engagement with healthcare professionals via transparency reports, continuing education content, and expert-co-developed patient materials. Schwabe Austria is governed by Managing Director Fritz Gamerith and operates under the regulatory oversight of BASG/AGES.

Commercially, the company generates revenue through one-time product sales of prescription and OTC phytopharmaceuticals and probiotics to Austrian pharmacy customers, with category coverage across cardiovascular, respiratory, anxiety/sleep, digestive, men's health, pediatric, and injury indications. The business model is anchored by long-standing physician and pharmacist recommendation behavior, a brand heritage inherited from the Schwabe Group, and a regulatory moat from registered medicinal product authorizations. The company is a member of Pharmig, IGEPHA, and FOPI, and was ranked the #1 pharmaceutical employer in Austria in the Leading Employers 2026 certification.

Name

Schwabe Austria

Legal name

Schwabe Austria GmbH

Website

https://schwabe.at

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Schwabe Austria GmbH is the Vienna-based Austrian subsidiary of the global Schwabe Group, marketing clinically supported phytopharmaceuticals, probiotics, and homeopathic medicines (e.g., Crataegutt, Lasea, Kaloba, Reloxan, pegaso) exclusively through Austrian pharmacies for adult and pediatric consumers.

Ownership category

akta.pro rank

Product category

Herbal Pharmaceuticals (Phytotherapy)

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (4242), Food (Health) Supplement Retailers (456191), Health and Personal Care Retailers (456)

SIC

Medicinal Chemicals & Botanical Products (2833), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYCRADAGAD

Herbal & Botanical Supplements

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

SECONDARYCRADAGAF

Probiotics & Digestive Health Supplements

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

SECONDARYCRADAGAJ

Children’s Vitamins & Supplements

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Vitamins, Supplements & Sports Nutrition

SECONDARYCRAFADAG

Health, Wellness & Pharmacy Online Retailers

Consumer Products & Retail/E-commerce & Marketplaces/Online Retailers (Inventory-led)

Keywords

• Herbal pharmaceuticals
• Phytotherapy products
• Plant-based medicines
• Probiotic supplements
• Homeopathic remedies

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Phytopharmaceutical product sales: Revenue is generated from the sale of prescription and OTC herbal medicinal products across therapeutic areas including anxiety (Lasea), heart health (Crataegutt), common cold (Kaloba), reflux (Reloxan), sleep disorders (Passedan), digestive issues (Gaspan), injuries (Traumeel), prostate health (Prostagutt duo), calmatives (Hametum, Cerebokan), and fatigue (Vitango). Products are sold through pharmacies as the primary retail channel.
2. Microbiome supplements (pegaso): Sale of probiotic supplements pegaso Baby and pegaso Junior for infant and child digestive health through pharmacies.

Go-to-market motion3 records

Distribution channels2 records

Marketing channels8 records

Core offering

Schwabe Austria develops, markets, and distributes a portfolio of proprietary phytopharmaceutical (herbal medicinal) products — including Lasea, Crataegutt, Kaloba, Passedan, Reloxan, Vitango, Prostagutt duo, and others — alongside the pegaso probiotic line for infant and child digestive health and the distributed Heel brand homeopathic products (Traumeel, Vertigoheel, Viburcol, Viburgel). All products are sold exclusively through Austrian pharmacies, both in-store and via pharmacy online ordering platforms.

Product overview

Schwabe Austria is a phytopharmaceutical company and expert in phytotherapy (plant-based medicine), operating as part of the global Schwabe Group. Its product portfolio consists of proprietary phytotherapy brands (Ceremin®, Cerebokan®, Crataegutt®, Gaspan®, Hametum®, Kaloba®, Lasea®, Passedan®, Prostagutt® duo, Reloxan®, Vitango®), a microbiology/probiotic line (pegaso® Baby and pegaso® Junior for infants and children), and distributed Heel brand homeopathic products (Traumeel®, Vertigoheel®, Viburcol®, Viburgel®). The portfolio spans cardiovascular health, respiratory/cold care, anxiety/stress/sleep, digestive issues, men's prostate health, and infant/microbiome care, unified by Schwabe Austria's focus on plant-derived medicinal products.

Differentiator

Problem solved

Functional benefit

Brands

• Phytofluencer: Social media influencer brand for phytotherapy education on Instagram

Products and services

• Ceremin® A phytopharmaceutical product offered by Schwabe Austria for a specific therapeutic area.
• Cerebokan®
• Crataegutt®
• Gaspan®
• Hametum®
• Kaloba®
• Lasea®
• Passedan®
• Prostagutt® duo
• Reloxan®
• Vitango®
• pegaso® Baby
• pegaso® Junior
• Traumeel®
• Vertigoheel®
• Viburcol®
• Viburgel®

Quantifiable outcome

• Leading Employers 2026: Ranked #1 pharmaceutical company in Austria, top 1% of employers

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Pharmig (Verband der pharmazeutischen Industrie Österreichs)coreOthersSchwabe Austria is a member of Pharmig, the Austrian Association of the Pharmaceutical Industry. Membership entails adherence to the Pharmig Code of Conduct and participation in the industry transparency initiative disclosing financial relationships with healthcare professionals.
• IGEPHA (The Austrian Consumer Health Care Association)coreOthersSchwabe Austria is a member of IGEPHA, the Austrian Consumer Health Care Association. Membership involves adherence to the IGEPHA Advertising Code and participation in industry self-regulation for consumer healthcare products.
• FOPI (Forum der forschenden pharmazeutischen Industrie in Österreich)coreOthersSchwabe Austria is a member of FOPI, representing Austria's research-based pharmaceutical industry. Membership supports engagement in research-oriented pharmaceutical policy and innovation advocacy.
• Österreichische Gesellschaft für Phytotherapie (ÖGPhyt)coreStrategic or Co-development PartnerSchwabe Austria supports the Austrian Society for Phytotherapy, an organization dedicated to promoting the scientific and clinical use of medicinal plants. The company is a sponsor of the society's activities.
• Südtiroler HerbstgesprächeminorStrategic or Co-development PartnerSchwabe Austria supports the South Tyrol Autumn Talks (Südtiroler Herbstgespräche), an event/conference series focused on phytotherapy topics.
• Österreichische Gesellschaft für homöopathische Medizin (ÖGHM)minorOthersSchwabe Austria supports the Austrian Society for Homeopathic Medicine through sponsorship.
• Ärztegesellschaft für klassische Homöopathie (ÄKH)minorOthersSchwabe Austria supports the Austrian Medical Association for Classical Homeopathy through sponsorship.
• Österreichische Gesellschaft für Veterinärmedizinische Homöopathie (ÖGVH)minorOthersSchwabe Austria supports the Austrian Society for Veterinary Homeopathy through sponsorship.
• Initiative Homöopathie hilftminorOthersSchwabe Austria supports the 'Homöopathie hilft' initiative through sponsorship.
• BASG/AGES Medizinmarktaufsicht (Bundesamt für Sicherheit im Gesundheitswesen)coreOthersRegulatory oversight authority for pharmaceutical products in Austria. Schwabe Austria operates under the supervision of BASG/AGES as required by the Austrian Medicinal Products Act (Arzneimittelgesetz).

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Schwabe Group (Dr. Willmar Schwabe GmbH & Co. KG): Parent company of Schwabe Austria and the originating entity of the Schwabe phytotherapy franchise. Comparable as the global parent with overlapping product families (Lasea, Kaloba, Crataegutt) distributed across multiple European markets.
• Rottapharm | Madaus (Rottapharm Biotech): European phytotherapy and natural health company combining Madaus and Rottapharm heritage. Directly comparable in herbal OTC portfolio (joint health, cardiovascular, respiratory) and pharmacy-led distribution across DACH and broader Europe.
• Hermes Arzneimittel GmbH: German herbal pharmaceutical company producing plant-based medicines for OTC pharmacy distribution, with overlapping indications (sleep, cold, digestion) and similar channel-led go-to-market approach.
• Bionorica SE: Germany-based direct peer and one of Europe's largest phytopharmaceutical companies. Bionorica competes head-to-head with Schwabe Austria in plant-based medicinal products across similar therapeutic areas (respiratory, urology, gynecology), with overlapping HCP and pharmacy-channel models.
• Biologische Heilmittel Heel GmbH: Sister company within the broader Schwabe/Heel ecosystem, focused on homeopathic combination products including Traumeel and Vertigoheel that Schwabe Austria distributes in Austria. Directly comparable for portfolio overlap and pharmacy-channel model.
• Engelhard Arzneimittel GmbH & Co. KG: Mid-sized German herbal pharma with comparable OTC phytotherapy products (e.g., Prospan for respiratory, isla for throat). Comparable business model as a family-owned herbal medicine specialist selling through pharmacy channels.
• Madaus (a Vifor Pharma company): German herbal pharmaceutical company with similar product positioning in digestive and urogenital health. Directly competes with Schwabe Austria brands like Gaspan and Prostagutt in DACH pharmacy channels.

Regional players

• Klosterfrau Melisana GmbH: DACH-focused herbal and traditional medicine brand with Klosterfrau Melissengeist and adjacent OTC remedies. Comparable as a regional herbal medicine specialist with similar Austrian/German pharmacy presence and brand-heritage positioning.

Broad incumbents

• Bayer Consumer Health (incl. Steigerwald): Global consumer health incumbent with broad OTC portfolio including phytotherapy lines (via Steigerwald). Competes indirectly with Schwabe Austria in pharmacy shelves across anxiety, cold, and digestive categories at much larger scale.
• Sanofi Consumer Healthcare (Opella): Global consumer health division of Sanofi with broad OTC portfolio in cough/cold, pain, and digestive health. Indirect competitor to Schwabe Austria's Kaloba and Gaspan brands via mass-market pharmacy distribution in Austria and DACH.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/schwabe-austria-gmbh
• Instagraminstagram.com/phytofluencer

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Schwabe Austria